165 related articles for article (PubMed ID: 36698236)
1. Discoidin Domain Receptor 1 Inhibitors: Advances and Future Directions for Novel Therapeutics with Aid of DNA Encoded Library Screens and Artificial Intelligence.
Sanawar R; Sahayasheela VJ; Sarath P; Dan VM
Mini Rev Med Chem; 2023; 23(15):1507-1513. PubMed ID: 36698236
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.
Day E; Waters B; Spiegel K; Alnadaf T; Manley PW; Buchdunger E; Walker C; Jarai G
Eur J Pharmacol; 2008 Dec; 599(1-3):44-53. PubMed ID: 18938156
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2.
Leitinger B
J Biol Chem; 2003 May; 278(19):16761-9. PubMed ID: 12611880
[TBL] [Abstract][Full Text] [Related]
4. Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor.
Abdulhussein R; McFadden C; Fuentes-Prior P; Vogel WF
J Biol Chem; 2004 Jul; 279(30):31462-70. PubMed ID: 15136580
[TBL] [Abstract][Full Text] [Related]
5. Collagen recognition and transmembrane signalling by discoidin domain receptors.
Carafoli F; Hohenester E
Biochim Biophys Acta; 2013 Oct; 1834(10):2187-94. PubMed ID: 23128141
[TBL] [Abstract][Full Text] [Related]
6. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Canning P; Tan L; Chu K; Lee SW; Gray NS; Bullock AN
J Mol Biol; 2014 Jun; 426(13):2457-70. PubMed ID: 24768818
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Cellular and Molecular Mechanism of Discoidin Domain Receptors (DDR1 and DDR2) in Bone Formation, Regeneration, and Its Associated Disease Conditions.
Mariadoss AVA; Wang CZ
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834343
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2.
Flynn LA; Blissett AR; Calomeni EP; Agarwal G
J Mol Biol; 2010 Jan; 395(3):533-43. PubMed ID: 19900459
[TBL] [Abstract][Full Text] [Related]
9. Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1.
Xu H; Raynal N; Stathopoulos S; Myllyharju J; Farndale RW; Leitinger B
Matrix Biol; 2011 Jan; 30(1):16-26. PubMed ID: 21044884
[TBL] [Abstract][Full Text] [Related]
10. The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2.
Leitinger B; Steplewski A; Fertala A
J Mol Biol; 2004 Dec; 344(4):993-1003. PubMed ID: 15544808
[TBL] [Abstract][Full Text] [Related]
11. Mapping of epitopes in discoidin domain receptor 1 critical for collagen binding.
Curat CA; Eck M; Dervillez X; Vogel WF
J Biol Chem; 2001 Dec; 276(49):45952-8. PubMed ID: 11598108
[TBL] [Abstract][Full Text] [Related]
12. Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling.
Carafoli F; Mayer MC; Shiraishi K; Pecheva MA; Chan LY; Nan R; Leitinger B; Hohenester E
Structure; 2012 Apr; 20(4):688-97. PubMed ID: 22483115
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening for potential discoidin domain receptor 1 (DDR1) inhibitors based on structural assessment.
Xie J; Meng D; Li Y; Li R; Deng P
Mol Divers; 2023 Oct; 27(5):2297-2314. PubMed ID: 36322341
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention.
Trono P; Ottavi F; Rosano' L
Matrix Biol; 2024 Jan; 125():31-39. PubMed ID: 38081526
[TBL] [Abstract][Full Text] [Related]
15. Normal activation of discoidin domain receptor 1 mutants with disulfide cross-links, insertions, or deletions in the extracellular juxtamembrane region: mechanistic implications.
Xu H; Abe T; Liu JK; Zalivina I; Hohenester E; Leitinger B
J Biol Chem; 2014 May; 289(19):13565-74. PubMed ID: 24671415
[TBL] [Abstract][Full Text] [Related]
16. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery.
Kothiwale S; Borza CM; Lowe EW; Pozzi A; Meiler J
Drug Discov Today; 2015 Feb; 20(2):255-61. PubMed ID: 25284748
[TBL] [Abstract][Full Text] [Related]
17. Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts.
Ruiz PA; Jarai G
J Biol Chem; 2011 Apr; 286(15):12912-23. PubMed ID: 21335558
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic insight into collagen recognition by discoidin domain receptor 2.
Carafoli F; Bihan D; Stathopoulos S; Konitsiotis AD; Kvansakul M; Farndale RW; Leitinger B; Hohenester E
Structure; 2009 Dec; 17(12):1573-1581. PubMed ID: 20004161
[TBL] [Abstract][Full Text] [Related]
19. Discoidin domain receptor 1 is activated independently of beta(1) integrin.
Vogel W; Brakebusch C; Fässler R; Alves F; Ruggiero F; Pawson T
J Biol Chem; 2000 Feb; 275(8):5779-84. PubMed ID: 10681566
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.
Toy KA; Valiathan RR; Núñez F; Kidwell KM; Gonzalez ME; Fridman R; Kleer CG
Breast Cancer Res Treat; 2015 Feb; 150(1):9-18. PubMed ID: 25667101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
